Abstract
In this research, we tried to recover the antioxidant activities of grape pomace by means of using solid-state cultivation (SSC) of Aspergillus niger BLAn1, Phanerochaete chrysosporium BLPc1, and Penicillium sp. BLPen1, three GRAS strains of fungi. We measured the enzymatic activities of β-glucosidase, responsible for liberating the aglycone forms of the phenolic compounds, as well as their total content. The highest β-glucosidase activities were approximately 17.2, 8.3, and 13.5 U · g-1 pomace for the 3 strains, respectively. The enzyme activity was considerably reduced with moisture-saturated air injection in the system. The total phenolic content obtained were 21.15, 12.13, and 10.08 mg GAE (Acid galic equivalent) · g-1 pomace, whereas the highest antioxidant activities released were 16.30, 11.35, and 10.57 mmol TEAC (Trolox equivalent antioxidant capacity) · g-1 pomace (by DPPH assay), and 158.61, 104.68, and 102.55 mmol TEAC · g-1 pomace (by ABTS assay), for BLAn1, BLPc1, and BLPen1, respectively. These results suggest that the enzyme hydrolysis of phenolic glycosides leads to increased concentrations of free phenolic compounds, enhancing radical- scavenging potential of pomace.
Keywords: β-glucosidase activity, bioactive compounds, grape pomace, phenolic glycosides, phytochemicals, solid-state cultivation.
Graphical Abstract
Current Bioactive Compounds
Title:Increased Content of Free Phenolic Compounds and Antioxidant Activity of Grape Pomace Cultivated with Three Different β-glucosidase Fungi Producers
Volume: 11 Issue: 2
Author(s): Natália G. Graebin, Plinho F. Hertz and Marco A. Z. Ayub
Affiliation:
Keywords: β-glucosidase activity, bioactive compounds, grape pomace, phenolic glycosides, phytochemicals, solid-state cultivation.
Abstract: In this research, we tried to recover the antioxidant activities of grape pomace by means of using solid-state cultivation (SSC) of Aspergillus niger BLAn1, Phanerochaete chrysosporium BLPc1, and Penicillium sp. BLPen1, three GRAS strains of fungi. We measured the enzymatic activities of β-glucosidase, responsible for liberating the aglycone forms of the phenolic compounds, as well as their total content. The highest β-glucosidase activities were approximately 17.2, 8.3, and 13.5 U · g-1 pomace for the 3 strains, respectively. The enzyme activity was considerably reduced with moisture-saturated air injection in the system. The total phenolic content obtained were 21.15, 12.13, and 10.08 mg GAE (Acid galic equivalent) · g-1 pomace, whereas the highest antioxidant activities released were 16.30, 11.35, and 10.57 mmol TEAC (Trolox equivalent antioxidant capacity) · g-1 pomace (by DPPH assay), and 158.61, 104.68, and 102.55 mmol TEAC · g-1 pomace (by ABTS assay), for BLAn1, BLPc1, and BLPen1, respectively. These results suggest that the enzyme hydrolysis of phenolic glycosides leads to increased concentrations of free phenolic compounds, enhancing radical- scavenging potential of pomace.
Export Options
About this article
Cite this article as:
Graebin G. Natália, Hertz F. Plinho and Ayub A. Z. Marco, Increased Content of Free Phenolic Compounds and Antioxidant Activity of Grape Pomace Cultivated with Three Different β-glucosidase Fungi Producers, Current Bioactive Compounds 2015; 11 (2) . https://dx.doi.org/10.2174/157340721102150820130901
DOI https://dx.doi.org/10.2174/157340721102150820130901 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
IP6 in Cancer Therapy: Past, Present and Future
Current Cancer Therapy Reviews Stem Cell Therapy for the Treatment of Acute Myocardial Infarction and Chronic Ischemic Heart Disease
Current Pharmaceutical Biotechnology Nebivolol: More Than a Highly Selective Beta Blocker
Recent Patents on Cardiovascular Drug Discovery Duration of Dual Antiplatelet Therapy After Coronary Stenting
Current Pharmaceutical Design Vitamin D and Metabolic Syndrome: Is There a Link?
Current Pharmaceutical Design Programs to Facilitate Tuberculosis Drug Discovery: The Tuberculosis Antimicrobial Acquisition and Coordinating Facility
Infectious Disorders - Drug Targets Relationship Between the Pharmacokinetics of Levosimendan and Its Effects on Cardiovascular System
Current Drug Metabolism Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Fetzima (levomilnacipran), a Drug for Major Depressive Disorder as a Dual Inhibitor for Human Serotonin Transporters and Beta-Site Amyloid Precursor Protein Cleaving Enzyme-1
CNS & Neurological Disorders - Drug Targets Elevated Heart Rate, A Risk Factor and Risk Marker of Cardiovascular Disease
Current Hypertension Reviews A Review of Systemic Vasodilators in Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery
Current Vascular Pharmacology A Review on Experimental Methods for Diabetes Induction and Therapeutic Efficacy of Anti-diabetic Drug Loaded Nanoformulation
Current Drug Therapy How to Advise Aspirin Use in Patients Who Need NSAIDs
Current Pharmaceutical Design Relationship Between Body Mass Index and Reproduction
Current Women`s Health Reviews Molecular Genetics of Left Ventricular Dysfunction
Current Molecular Medicine Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases
Current Topics in Medicinal Chemistry Adiponectin: Merely a Bystander or the Missing Link to Cardiovascular Disease?
Current Topics in Medicinal Chemistry Anti-Inflammatory Activity of Polysaccharide Fraction of Curcuma longa Extract (NR-INF-02)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Peironimev-Plus® in the Treatment of Chronic Inflammation of Tunica Albuginea (Peyronie’s Disease). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued) Adenosine Receptor Ligands-Recent Developments Part I. Agonists
Current Medicinal Chemistry